Evidence map›Paper›PMID 27912758›Full record

ArticleMalaria journal2016

Emerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India.

Neelima Mishra, Ram Suresh Bharti, Prashant Mallick, Om Prakash Singh, Bina Srivastava, Roma Rana, Sobhan Phookan, Hardev Prasad Gupta, Pascal Ringwald, Neena Valecha

Abstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Antibody Responses to the ConservedPathogens (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Artemisinin-resistant malaria.Clinical microbiology reviews · 2024
    Review
  8. Spatiotemporal Epidemiology of Malaria in India from 2007 to 2022.The American journal of tropical medicine and hygiene · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. An analysis ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Neelima MishraNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Ram Suresh BhartiNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Prashant MallickNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Om Prakash SinghNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Bina SrivastavaNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Roma RanaNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Sobhan PhookanNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Hardev Prasad GuptaNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India.
Pascal RingwaldGlobal Malaria Programme, Geneva, Switzerland.
Neena ValechaNational Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110 077, India. neenavalecha@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent reports of emergence and spread of artemisinin resistance in the Southeast Asia region, including Myanmar, pose a greater threat to malaria control and elimination in India. Whole genome sequencing studies have associated mutations in the K13 propeller gene (k13), PF3D7_1343700 with artemisinin resistance both in vitro and in vivo. The aim of the present study was to find the k13 gene polymorphisms in Plasmodium falciparum parasites from the three sites in the Northeast region of India, bordering Bangladesh and Myanmar.

methodsA total of 254 samples collected during 2014-2015 from Tripura, Mizoram and Arunachal Pradesh states in the Northeast region of India were used to obtain the full-length k13 gene sequences.

resultsThree non-synonymous (NS) mutations: two in the propeller region, namely at codon 446 and 578, were observed besides one at codon 189 in the non-propeller region. The treatment outcome was not affected by these mutations at any of the sites. In addition, microsatellite variation in the N-terminus of the k13 protein was observed at all the study sites.

conclusionThis is the first study to document the presence of F446I NS mutation in the k13 propeller region from Changlang district, Arunachal Pradesh, a site adjoining the Indo-Myanmar border region, where this mutation is highly prevalent. In addition, NS mutation A578S has been observed only at Lunglei district, Mizoram, a site bordering Bangladesh and K189T mutation with relatively higher frequency in Mizoram and Tripura states. The presence of F446I mutation in a region close to the Myanmar border is notable. Considering the spread of anti-malarial drug resistance from Southeast Asia to the Northeast region of India in the past, there is an urgent need to undertake systematic mapping studies to ascertain the role and extent of this mutation in artemisinin resistance in this region of country.

Indexed as

Mutation, MissensePolymorphism, GeneticDrug ResistanceHumansIndiaMalaria, FalciparumMolecular EpidemiologyPlasmodium falciparumProtozoan ProteinsSequence Analysis, DNAProtozoan ProteinsArtemisinin resistanceK13 geneMalariaPF3D7_1343700Plasmodium falciparum

Identifiers

PMID27912758
PMCPMC5135801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.